CDH1 and Familial gastric cancer: These estimates demonstrate the significance of the CDH1 germline mutations in developing HDGC and LBC, especially when considering that the lifetime risk of the general population in developing these cancers is 0.9% in either gender for diffuse gastric cancer (DGC) and 12% for breast cancer (BC) in females [2].